Raoul Herbrecht Selected Research

Sodium Glutamate (Accent)

11/2018	Treatment outcomes in patients with proven/probable vs possible invasive mould disease in a phase III trial comparing isavuconazole vs voriconazole.
3/2015	Application of the 2008 definitions for invasive fungal diseases to the trial comparing voriconazole versus amphotericin B for therapy of invasive aspergillosis: a collaborative study of the Mycoses Study Group (MSG 05) and the European Organization for Research and Treatment of Cancer Infectious Diseases Group.
9/2011	Efficacy outcomes in a randomised trial of liposomal amphotericin B based on revised EORTC/MSG 2008 definitions of invasive mould disease.
6/2010	Computer tomography in pulmonary invasive aspergillosis in hematological patients with neutropenia: an useful tool for diagnosis and assessment of outcome in clinical trials.
6/2008	Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Raoul Herbrecht Research Topics

Disease

40	Aspergillosis 01/2023 - 03/2002
33	Infections 05/2022 - 03/2002
30	Neoplasms (Cancer) 05/2022 - 04/2002
26	Mycoses (Diseases, Fungus) 04/2022 - 04/2003
19	Neutropenia 03/2020 - 04/2002
8	Hematologic Neoplasms (Hematological Malignancy) 11/2023 - 12/2004
8	Leukemia 05/2022 - 05/2002
8	Invasive Fungal Infections 05/2020 - 05/2006
7	Candidiasis (Moniliasis) 01/2019 - 03/2003
6	Febrile Neutropenia 01/2022 - 08/2005
6	Mucormycosis 01/2022 - 01/2010
6	Invasive Candidiasis 01/2019 - 03/2003
5	Non-Hodgkin Lymphoma (Lymphosarcoma) 04/2011 - 12/2003
5	Lymphoma (Lymphomas) 11/2010 - 05/2002
4	Fever (Fevers) 11/2021 - 04/2003
4	Communicable Diseases (Infectious Diseases) 01/2021 - 08/2004
4	Candidemia 01/2019 - 04/2012
4	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2018 - 01/2002
4	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 03/2015 - 07/2009
3	Invasive Pulmonary Aspergillosis 05/2020 - 04/2005
3	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 08/2015 - 07/2009
3	Fusariosis 10/2010 - 12/2004
3	Chills 08/2005 - 01/2003
2	Anemia 02/2022 - 08/2009
2	Coinfection 11/2021 - 12/2012
2	Primary Myelofibrosis (Myelosclerosis) 12/2020 - 03/2019
2	Agranulocytosis (Granulocytopenia) 03/2020 - 01/2017
2	Graft vs Host Disease (Graft-Versus-Host Disease) 03/2020 - 04/2006
2	Sepsis (Septicemia) 09/2017 - 01/2017
2	Pneumonia (Pneumonitis) 09/2017 - 12/2004
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2014 - 07/2006
2	Acute Kidney Injury (Acute Renal Failure) 07/2013 - 11/2010
2	Disease Progression 07/2011 - 04/2003
2	Pleural Effusion (Pleural Effusions) 11/2008 - 04/2006
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 09/2006 - 04/2006
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 07/2006 - 05/2002
2	Hematologic Diseases (Blood Diseases) 04/2006 - 08/2002
2	Body Weight (Weight, Body) 12/2004 - 08/2002
1	Cytopenia 10/2023
1	Hypogonadism (Hypergonadotropic Hypogonadism) 02/2022
1	beta-Thalassemia (Cooley's Anemia) 02/2022

Drug/Important Bio-Agent (IBA)

17	Voriconazole (Vfend)FDA LinkGeneric 01/2019 - 03/2002
16	Amphotericin B (Amphotericin)FDA LinkGeneric 12/2018 - 08/2002
9	Caspofungin (Cancidas)FDA Link 01/2019 - 03/2003
8	liposomal amphotericin B FDA Link 11/2019 - 08/2003
7	galactomannanIBA 01/2023 - 04/2002
7	Fluconazole (Zonal)FDA LinkGeneric 01/2022 - 03/2003
7	Antifungal AgentsIBA 01/2021 - 04/2003
7	isavuconazoleIBA 06/2020 - 02/2016
5	posaconazole FDA Link 11/2019 - 12/2004
5	Sodium Glutamate (Accent)IBA 11/2018 - 06/2008
5	Biomarkers (Surrogate Marker)IBA 01/2018 - 09/2006
5	Anti-Bacterial Agents (Antibiotics)IBA 01/2017 - 01/2003
5	TriazolesIBA 01/2017 - 08/2004
5	LipidsIBA 01/2015 - 05/2003
4	EchinocandinsIBA 01/2017 - 12/2006
4	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2011 - 01/2002
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2011 - 01/2002
4	Vincristine (Oncovin)FDA LinkGeneric 04/2011 - 01/2002
3	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 01/2018
3	SteroidsIBA 01/2020 - 04/2006
3	Immunosuppressive Agents (Immunosuppressants)IBA 01/2020 - 05/2009
3	CytokinesIBA 01/2019 - 11/2010
3	deoxycholate drug combination amphotericin BIBA 01/2017 - 08/2002
3	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2012 - 11/2008
3	Methotrexate (Mexate)FDA LinkGeneric 11/2011 - 12/2009
3	Rituximab (Mabthera)FDA Link 08/2011 - 01/2002
3	Prednisone (Sone)FDA LinkGeneric 04/2011 - 01/2002
3	Proteins (Proteins, Gene)FDA Link 11/2010 - 09/2006
2	AntibodiesIBA 10/2023 - 05/2016
2	Phosphotransferases (Kinase)IBA 01/2022 - 08/2009
2	ruxolitinibIBA 12/2020 - 03/2019
2	Monoclonal AntibodiesIBA 01/2020 - 01/2002
2	DisaccharidesIBA 12/2019 - 01/2019
2	Micafungin (FK463)FDA Link 07/2019 - 01/2015
2	Anidulafungin FDA Link 01/2017 - 01/2017
2	EnzymesIBA 11/2009 - 04/2002
2	ImmunosorbentsIBA 11/2009 - 04/2002
2	SuspensionsIBA 01/2007 - 05/2006
2	Colistin (Coly-Mycin)FDA Link 08/2005 - 01/2003
1	Immunoglobulins (Immunoglobulin)IBA 10/2023
1	IronIBA 02/2022
1	venetoclaxIBA 01/2022
1	midostaurinIBA 01/2022
1	quizartinibIBA 01/2022
1	gilteritinibIBA 01/2022
1	glasdegibIBA 01/2022
1	Inotuzumab OzogamicinIBA 01/2022

Therapy/Procedure

50	Therapeutics 06/2020 - 03/2002
13	Drug Therapy (Chemotherapy) 08/2020 - 01/2002
8	Hematopoietic Stem Cell Transplantation 11/2023 - 04/2002
7	Organ Transplantation 11/2023 - 09/2006
6	Transplantation 05/2022 - 04/2006
6	Salvage Therapy 01/2015 - 12/2004
5	Stem Cell Transplantation 11/2021 - 08/2011
3	Aftercare (After-Treatment) 01/2022 - 07/2006
3	Induction Chemotherapy 11/2014 - 12/2003
2	Biological Therapy 05/2022 - 01/2022
2	Cell Transplantation 01/2015 - 08/2002
1	Cesarean Section (Caesarean Section) 02/2022